A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Odalasvir and AL-335 Alone and in Combination With Simeprevir in Participants With Moderately Impaired Hepatic Function
PHASE1
The purpose of this study is to evaluate the pharmacokinetics (PK) of AL-33...
A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
PHASE3
This is a 6-month, open-label, flexible-dose study evaluating Desvenlafaxin...
Status
Completed
Location
The University Of Alabama At Birmingham, Office Of Psychiatric Research
Pharmacokinetics and Safety of Desvenlafaxine in Korean Healthy Subjects Following Single and Multiple Oral Doses of Desvenlafaxine Succinate Sustained Release Tablet
PHASE1
To evaluate the pharmacokinetics and safety of single dose and multiple dos...